Opposing Role of Trust as a Modifier of COVID-19 Vaccine Uptake in an Indigenous Population
Abstract
:Structured Abstract
- Importance: Native Hawaiians and other Pacific Islanders (NHPIs) were disproportionately impacted by COVID-19 and remain significantly under-vaccinated against SARS-CoV-2. Understanding vaccine hesitancy may improve vaccination uptake among NHPI and public health policy.
- Objective: To examine how trust and COVID-19 information influence vaccine uptake in an indigenous population with low vaccination coverage disproportionately impacted by COVID-19.
- Design: The NIH RADx-UP survey includes demographics, vaccination status, media consumption, and trust in sources of COVID-19 information and was collected from March to August 2021.
- Setting: Adult residents of Hawaii completed an online survey via Qualtrics and participated in COVID-19 testing.
- Participants: A total of 1124 adults participated in the RADx-UP survey: 61.7% self-identified as Native Hawaiian and Pacific Islander, 17.4% Asian, 13.0% Caucasian, and 7.7% Other; 63% were women; 29.0% were 18–29, 23.0% were 30–39, 21.0% were 40–49, 17.0% were 50–59, 7.3% were 60–69, and 2.8% were 70 years old or older.
- Main outcomes or measures: Consumption of COVID-19 information, degree of trust in sources of COVID-19 information, and sociodemographic factors were measured in association with COVID-19 vaccine uptake.
- Results: Among individuals that exhibited a higher degree of trust in official sources of COVID-19 information, we observed an increased probability of vaccination by 20.68%, whereas those that exhibited a higher degree of trust in unofficial sources had a decreased probability of vaccination by 12.49%, revealing a dual and opposing role of trust in vaccine uptake. Unlike age, sex, and education level, race/ethnicity was not an independent modifier of vaccine uptake. Trust in unofficial sources along with consumption of COVID-19 information from such sources explained vaccine hesitancy, specifically among NHPIs.
- Conclusion and Relevance: The results offer novel insights into how the degree of trust in sources of COVID-19 information, frequency of consumption of COVID-19 information, and sociodemographic factors interact to influence vaccine uptake and offer novel insight relevant to public health policy in other similarly vulnerable minority populations in the US.
1. Introduction
2. Methods
2.1. Recruitment Strategy
2.2. Survey Instrument
2.3. Statistical Analysis of Survey Data and Probabilistic Model
3. Results
3.1. Opposing Role of Trust in Modifying Vaccine Hesitancy
3.2. Race/Ethnicity Alone Is Not a Modifier of Vaccine Uptake in NHPIs
3.3. Age, Sex, and Education Level as Co-Modifiers of Vaccine Uptake
4. Discussion
4.1. Limitations
4.2. Conclusions and Future Directions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Muñoz-Price, L.S.; Nattinger, A.B.; Rivera, F.; Hanson, R.; Gmehlin, C.G.; Perez, A.; Singh, S.; Buchan, B.W.; Ledeboer, N.A.; Pezzin, L.E. Racial Disparities in Incidence and Outcomes among Patients with COVID-19. JAMA Netw. Open 2020, 3, e2021892. [Google Scholar] [CrossRef] [PubMed]
- Hawaii State Department of Health. Available online: https://health.hawaii.gov/coronavirusdisease2019/current-situation-in-hawaii (accessed on 24 September 2021).
- Mau, M.K.; Sinclair, K.; Saito, E.P.; Baumhofer, K.N.; Kaholokula, J.K. Cardiometabolic Health Disparities in Native Hawaiians and Other Pacific Islanders. Epidemiol. Rev. 2009, 31, 113–129. [Google Scholar] [CrossRef] [Green Version]
- Mokuau, N.; DeLeon, P.H.; Kaholokula, J.K.; Soares, S.; Tsark, J.U.; Haia, C. Challenges and Promise of Health Equity for Native Hawaiians. NAM Perspect. 2016. [Google Scholar] [CrossRef] [Green Version]
- McEligot, A.J.; McMullin, J.; Pang, K.; Bone, M.; Winston, S.; Ngewa, R.; Tanjasiri, S.P. Diet, Psychosocial Factors Related to Diet and Exercise, and Cardiometabolic Conditions in Southern Californian Native Hawaiians. Hawaii Med. J. 2010, 69, 16. [Google Scholar] [PubMed]
- Furubayashi, J.K.; Look, M.A. Type 2 Diabetes in Native Hawaiians and Pacific Islanders in Hawaii. Pac. Health Dialog 2005, 12, 103–110. [Google Scholar] [PubMed]
- Wong, L.L.; Kindle, K.; Limm, B. Racial Disparities in Pacific Islanders Undergoing Renal Transplant Evaluation. Hawaii Med. J. 2009, 68, 30–33. [Google Scholar]
- Lee, R.; Onopa, J.; Mau, M.K.; Seto, T.B. Diabetes Care in a Predominantly Native Hawaiian and Pacific Islander Outpatient Population. Hawaii Med. J. 2010, 69, 28. [Google Scholar]
- Andrasik, M.P.; Maunakea, A.K.; Oseso, L.; Rodriguez-Diaz, C.E.; Wallace, S.; Walters, K.; Yukawa, M. Awakening: The Unveiling of Historically Unaddressed Social Inequities during the COVID-19 Pandemic in the United States. Infect. Dis. Clin. 2022, 36, 295–308. [Google Scholar] [CrossRef]
- Latkin, C.A.; Dayton, L.; Yi, G.; Konstantopoulos, A.; Boodram, B. Trust in a COVID-19 Vaccine in the US: A Social-Ecological Perspective. Soc. Sci. Med. 2021, 270, 113684. [Google Scholar] [CrossRef]
- Loomba, S.; de Figueiredo, A.; Piatek, S.J.; de Graaf, K.; Larson, H.J. Measuring the Impact of COVID-19 Vaccine Misinformation on Vaccination Intent in the UK and USA. Nat. Hum. Behav. 2021, 5, 337–348. [Google Scholar] [CrossRef]
- National Institutes of Health RADx-UP Initiative. Available online: https://www.nih.gov/research-training/medical-research-initiatives/radx/radx-programs#radx-up (accessed on 24 September 2021).
- Juarez, R.; Siegal, N.; Maunakea, A.K. The Effects of COVID-19 Vaccine Mandates in Hawaii. Vaccines 2022, 10, 773. [Google Scholar] [CrossRef] [PubMed]
- Wooldridge, J.M. Introductory Econometrics: A Modern Approach; Cengage Learning: Boston, MA, USA, 2015. [Google Scholar]
- Greene, W.H. Econometric Analysis, 4th ed.; Prentice Hall: New York, NY, USA, 2000. [Google Scholar]
- Quint, J.J.; van Dyke, M.E.; Maeda, H.; Worthington, J.K.; dela Cruz, M.R.; Kaholokula, J.K.; Matagi, C.E.; Pirkle, C.M.; Roberson, E.K.; Sentell, T.; et al. Disaggregating Data to Measure Racial Disparities in COVID-19 Outcomes and Guide Community Response—Hawaii, 1 March 2020–28 February 2021. Morb. Mortal. Wkly. Rep. 2021, 70, 1267. [Google Scholar] [CrossRef] [PubMed]
- Penaia, C.S.; Morey, B.N.; Thomas, K.B.; Chang, R.C.; Tran, V.D.; Pierson, N.; Greer, J.; Ponce, N.A. Disparities in Native Hawaiian and Pacific Islander COVID-19 Mortality: A Community-Driven Data Response. Am. J. Public Health 2021, 111, S49–S52. [Google Scholar] [CrossRef] [PubMed]
- Wang, D.; Gee, G.C.; Bahiru, E.; Yang, E.H.; Hsu, J.J. Asian-Americans and Pacific Islanders in COVID-19: Emerging Disparities amid Discrimination. J. Gen. Intern. Med. 2020, 35, 3685–3688. [Google Scholar] [CrossRef] [PubMed]
- Miyachi, T.; Takita, M.; Senoo, Y.; Yamamoto, K. Lower Trust in National Government Links to No History of Vaccination. Lancet 2020, 395, 31–32. [Google Scholar] [CrossRef] [Green Version]
- Rodriguez-Morales, A.J.; Franco, O.H. Public Trust, Misinformation and COVID-19 Vaccination Willingness in Latin America and the Caribbean: Today’s Key Challenges. Lancet Reg. Health—Am. 2021, 3, 100073. [Google Scholar] [CrossRef]
- Purvis, R.S.; Hallgren, E.; Moore, R.A.; Willis, D.E.; Hall, S.; Gurel-Headley, M.; McElfish, P.A. Trusted Sources of COVID-19 Vaccine Information among Hesitant Adopters in the United States. Vaccines 2021, 9, 1418. [Google Scholar] [CrossRef]
- McFadden, S.M.; Malik, A.A.; Aguolu, O.G.; Willebrand, K.S.; Omer, S.B. Perceptions of the Adult US Population Regarding the Novel Coronavirus Outbreak. PLoS ONE 2020, 15, e0231808. [Google Scholar] [CrossRef]
- Fridman, I.; Lucas, N.; Henke, D.; Zigler, C.K. Association between Public Knowledge about COVID-19, Trust in Information Sources, and Adherence to Social Distancing: Cross-Sectional Survey. JMIR Public Health Surveill. 2020, 6, e22060. [Google Scholar] [CrossRef]
- Boyle, J.; Brassell, T.; Dayton, J. As Cases Increase, American Trust in COVID-19 Information from Federal, State, and Local Governments Continues to Decline. ICF Int. 2020. [Google Scholar]
- Earnshaw, V.A.; Eaton, L.A.; Kalichman, S.C.; Brousseau, N.M.; Hill, E.C.; Fox, A.B. COVID-19 Conspiracy Beliefs, Health Behaviors, and Policy Support. Transl. Behav. Med. 2020, 10, 850–856. [Google Scholar] [CrossRef] [PubMed]
- Pertwee, E.; Simas, C.; Larson, H.J. An Epidemic of Uncertainty: Rumors, Conspiracy Theories and Vaccine Hesitancy. Nat. Med. 2022, 28, 456–459. [Google Scholar] [CrossRef] [PubMed]
- Roozenbeek, J.; Schneider, C.R.; Dryhurst, S.; Kerr, J.; Freeman, A.L.J.; Recchia, G.; van der Bles, A.M.; van der Linden, S. Susceptibility to Misinformation about COVID-19 around the World. R. Soc. Open Sci. 2020, 7, 201199. [Google Scholar] [CrossRef] [PubMed]
- Ochieng, C.; Anand, S.; Mutwiri, G.; Szafron, M.; Alphonsus, K. Factors Associated with COVID-19 Vaccine Hesitancy among Visible Minority Groups from a Global Context: A Scoping Review. Vaccines 2021, 9, 1445. [Google Scholar] [CrossRef]
- Mosby, I.; Swidrovich, J. Medical Experimentation and the Roots of COVID-19 Vaccine Hesitancy among Indigenous Peoples in Canada. Can. Med. Assoc. J. 2021, 193, E381–E383. [Google Scholar] [CrossRef] [PubMed]
- Newman, P.A.; Reid, L.; Tepjan, S.; Fantus, S.; Allan, K.; Nyoni, T.; Guta, A.; Williams, C.C. COVID-19 Vaccine Hesitancy among Marginalized Populations in the US and Canada: Protocol for a Scoping Review. PLoS ONE 2022, 17, e0266120. [Google Scholar] [CrossRef]
- Mehmood, Q.; Tebha, S.S.; Abdullahi Tunde Aborode, A. COVID-19 Vaccine Hesitancy among Indigenous People in India: An Incipient Crisis. Eth. Med. Public Health 2021, 19, 100727. [Google Scholar] [CrossRef]
- Danabal, K.G.M.; Magesh, S.S.; Saravanan, S.; Gopichandran, V. Attitude towards COVID 19 Vaccines and Vaccine Hesitancy in Urban and Rural Communities in Tamil Nadu, India—A Community Based Survey. BMC Health Serv. Res. 2021, 21, 1–10. [Google Scholar] [CrossRef]
- Swed, S.; Mohamed, T.; Sakkour, R.; Motawea, K.R.; Bohsas, H. COVID-19 Vaccine Hesitancy among Indigenous People in Sudan: An Incipient Crisis. Ann. Med. Surg. 2022, 75. [Google Scholar] [CrossRef]
- Almoughales, A.A.; Swed, S.; Sawaf, B.; Alibrahim, H. COVID-19 Vaccine Hesitancy among Indigenous People in Yemen: An Incipient Crisis. Ann. Med. Surg. 2022, 73, 103206. [Google Scholar] [CrossRef]
- Hildreth, J.E.K.; Alcendor, D.J. Targeting COVID-19 Vaccine Hesitancy in Minority Populations in the US: Implications for Herd Immunity. Vaccines 2021, 9, 489. [Google Scholar] [CrossRef] [PubMed]
- Nguyen, L.H.; Joshi, A.D.; Drew, D.A.; Merino, J.; Ma, W.; Lo, C.-H.; Kwon, S.; Wang, K.; Graham, M.S.; Polidori, L.; et al. Racial and Ethnic Differences in COVID-19 Vaccine Hesitancy and Uptake. medRxiv 2021. [Google Scholar] [CrossRef]
- Razai, M.S.; Osama, T.; McKechnie, D.G.J.; Majeed, A. COVID-19 Vaccine Hesitancy among Ethnic Minority Groups. Bmj 2021, 372, n513. [Google Scholar] [CrossRef] [PubMed]
- Juarez, R.; Phankitnirundorn, K.; Ramirez, A.; Peres, R.; Maunakea, A.K.; Okihiro, M. Vaccine Associated Shifts in SARS-CoV-2 Infectivity among the Native Hawaiian and Other Pacific Islander Population in Hawaii. Am. J. Public Health 2022. [Google Scholar]
- Gorelik, Y.; Anis, E.; Edelstein, M. Inequalities in Initiation of COVID-19 Vaccination by Age and Population Group in Israel-December 2020–July 2021. Lancet Reg. Health—Eur. 2022, 12, 100234. [Google Scholar] [CrossRef]
- Lazarus, J.V.; Wyka, K.; Rauh, L.; Rabin, K.; Ratzan, S.; Gostin, L.O.; Larson, H.J.; El-Mohandes, A. Hesitant or Not? The Association of Age, Gender, and Education with Potential Acceptance of a COVID-19 Vaccine: A Country-Level Analysis. J. Health Commun. 2020, 25, 799–807. [Google Scholar] [CrossRef]
- Malik, A.A.; McFadden, S.M.; Elharake, J.; Omer, S.B. Determinants of COVID-19 Vaccine Acceptance in the US. EClinicalMedicine 2020, 26, 100495. [Google Scholar] [CrossRef]
- Robertson, E.; Reeve, K.S.; Niedzwiedz, C.L.; Moore, J.; Blake, M.; Green, M.; Katikireddi, S.V.; Benzeval, M.J. Predictors of COVID-19 Vaccine Hesitancy in the UK Household Longitudinal Study. Brain Behav. Immun. 2021, 94, 41–50. [Google Scholar] [CrossRef]
- Yoon, P.; Hall, J.; Fuld, J.; Mattocks, S.L.; Lyons, B.C.; Bhatkoti, R.; Henley, J.; McNaghten, A.D.; Daskalakis, D.; Pillai, S.K. Alternative Methods for Grouping Race and Ethnicity to Monitor COVID-19 Outcomes and Vaccination Coverage. Morb. Mortal. Wkly. Rep. 2021, 70, 1075. [Google Scholar] [CrossRef]
- Ghaffari-Rafi, A.; Teehera, K.B.; Higashihara, T.J.; Morden, F.T.C.; Goo, C.; Pang, M.; Sutton, C.X.Y.; Kim, K.M.; Lew, R.J.; Luu, K.; et al. Variables Associated with Coronavirus Disease 2019 Vaccine Hesitancy Amongst Patients with Neurological Disorders. Infect. Dis. Rep. 2021, 13, 763–810. [Google Scholar] [CrossRef]
- Truelove, S.; Smith, C.P.; Qin, M.; Mullany, L.C.; Borchering, R.K.; Lessler, J.; Shea, K.; Howerton, E.; Contamin, L.; Levander, J.; et al. Projected Resurgence of COVID-19 in the United States in July–December 2021 Resulting from the Increased Transmissibility of the Delta Variant and Faltering Vaccination. medRxiv, 2021; preprint. [Google Scholar] [CrossRef]
Demographics | Overall, N = 1124 | Vaccinated, N = 637 | Unvaccinated, N = 487 | |||
---|---|---|---|---|---|---|
Vaccination status | N | % | N | % | N | % |
Vaccinated | 637 | 57.0% | NA | NA | NA | NA |
Age Group | N | % | N | % | N | % |
18–29 | 323 | 29.0% | 136 | 21.0% | 187 | 38.0% |
30–39 | 254 | 23.0% | 129 | 20.0% | 125 | 26.0% |
40–49 | 240 | 21.0% | 143 | 22.0% | 97 | 20.0% |
50–59 | 193 | 17.0% | 137 | 22.0% | 56 | 11.0% |
60–69 | 82 | 7.3% | 62 | 9.7% | 20 | 4.1% |
70+ | 32 | 2.8% | 30 | 4.7% | 2 | 0.4% |
Sex | N | % | Mean | % | N | % |
Female | 708 | 63.0% | 408 | 64.0% | 300 | 61.0% |
Male | 416 | 37.0% | 229 | 36.0% | 187 | 38.0% |
Education | N | % | N | % | N | % |
9th to 12th grade, no diploma | 54 | 4.8% | 18 | 2.8% | 36 | 7.4% |
High school graduate or GED completed | 407 | 36.0% | 164 | 26.0% | 243 | 50.0% |
Some college level/Technical/Vocational degree | 269 | 24.0% | 159 | 25.0% | 110 | 23.0% |
Bachelor’s degree | 174 | 15.0% | 121 | 19.0% | 53 | 11.0% |
Other advanced degree (Master’s, Doctoral degree) | 220 | 20.0% | 175 | 27.0% | 45 | 9.2% |
Trust—Official Source of COVID-19 Information 1 | Mean | SD | Mean | SD | Mean | SD |
U.S. Government | 1.18 | 1.10 | 1.42 | 1.12 | 0.85 | 0.98 |
U.S. Coronavirus task force | 1.32 | 1.17 | 1.55 | 1.21 | 1.01 | 1.04 |
Doctor or health care provider | 1.92 | 1.23 | 2.07 | 1.24 | 1.74 | 1.18 |
News on the radio, TV, online, or in newspapers | 1.17 | 1.05 | 1.36 | 1.06 | 0.92 | 0.99 |
Average overall | 1.40 | 1.00 | 1.60 *** | 1.05 | 1.13 | 0.87 |
Trust—Unofficial Source of COVID-19 Information 1 | Mean | SD | Mean | SD | Mean | SD |
Faith leaders | 1.09 | 1.24 | 1.00 | 1.23 | 1.21 | 1.25 |
Close friends and family members | 1.56 | 1.15 | 1.58 | 1.15 | 1.53 | 1.16 |
Classmates, colleagues or other people you know | 1.27 | 1.06 | 1.34 | 1.07 | 1.19 | 1.04 |
Contacts on social media | 0.80 | 0.94 | 0.82 | 0.96 | 0.76 | 0.91 |
Average overall | 1.18 | 0.89 | 1.19 | 0.90 | 1.17 | 0.86 |
Consumption—Official Source of COVID-19 Information 2 | ||||||
Local government officials (e.g., Governor, Mayor) | 1.47 | 1.17 | 1.66 | 1.21 | 1.23 | 1.07 |
Federal government (e.g., President, White House Coronavirus Task Force) | 1.44 | 1.17 | 1.64 | 1.22 | 1.19 | 1.05 |
Print or online news | 1.40 | 1.13 | 1.52 | 1.17 | 1.24 | 1.04 |
TV or radio | 1.36 | 1.12 | 1.48 | 1.16 | 1.20 | 1.04 |
Healthcare providers (e.g., Personal Physician/Doctor, Pharmacist, etc.) | 1.79 | 1.27 | 1.88 | 1.34 | 1.68 | 1.17 |
Medical/Health websites (e.g., CDC, WebMD, etc.) | 1.65 | 1.21 | 1.77 | 1.26 | 1.48 | 1.11 |
Average overall | 1.52 | 1.01 | 1.66 ** | 1.07 | 1.34 | 0.91 |
Consumption—Unofficial Source of COVID-19 Information 2 | ||||||
Friends, family or neighbors (not including social media) | 1.43 | 1.14 | 1.38 | 1.15 | 1.50 | 1.13 |
Social media (e.g., Instagram, Facebook, YouTube, TikTok, etc.) | 1.05 | 1.08 | 1.03 | 1.10 | 1.08 | 1.05 |
Average overall | 1.24 | 0.98 | 1.21 | 1.01 | 1.29 | 0.95 |
Demographics | NHPI, N = 694 | Asian, N = 196 | White, N = 147 | Other, N = 87 | ||||
---|---|---|---|---|---|---|---|---|
Vaccination status | N | % | N | % | N | % | N | % |
Vaccinated | 352 | 51.0% | 146 | 74.0% | 104 | 71.0% | 35 | 40.0% |
Age Group | N | % | N | % | N | % | N | % |
18–29 | 222 | 32.0% | 43 | 22.0% | 31 | 21.0% | 27 | 31.0% |
30–39 | 164 | 24.0% | 41 | 21.0% | 29 | 20.0% | 20 | 23.0% |
40–49 | 150 | 22.0% | 39 | 20.0% | 33 | 22.0% | 18 | 21.0% |
50–59 | 107 | 15.0% | 43 | 22.0% | 29 | 20.0% | 14 | 16.0% |
60–69 | 34 | 4.9% | 25 | 13.0% | 16 | 11.0% | 7 | 8.0% |
70+ | 17 | 2.4% | 5 | 2.6% | 9 | 6.1% | 1 | 1.1% |
Gender | N | % | N | % | N | % | N | % |
Female | 451 | 65.0% | 124 | 63.0% | 93 | 63.0% | 40 | 46.0% |
Male | 243 | 35.0% | 72 | 36.0% | 54 | 37.0% | 47 | 54.0% |
Education | N | % | N | % | N | % | N | % |
9th to 12th grade, no diploma | 42 | 6.1% | 1 | 0.5% | 6 | 4.1% | 5 | 5.7% |
High school graduate or GED completed | 322 | 46.0% | 37 | 19.0% | 16 | 11.0% | 32 | 37.0% |
Some college level/Technical/Vocational degree | 169 | 24.0% | 53 | 27.0% | 26 | 18.0% | 21 | 24.0% |
Bachelor’s degree | 77 | 11.0% | 46 | 23.0% | 36 | 24.0% | 15 | 17.0% |
Other advanced degree (Master’s, Doctoral degree) | 84 | 12.0% | 59 | 30.0% | 63 | 43.0% | 14 | 16.0% |
Trust—Official Source of COVID-19 Information 1 | Mean | SD | Mean | SD | Mean | SD | Mean | SD |
U.S. Government | 1.11 | 1.06 | 1.39 | 1.14 | 1.30 | 1.2 | 1.02 | 1.06 |
U.S. Coronavirus task force | 1.26 | 1.13 | 1.47 | 1.20 | 1.46 | 1.29 | 1.09 | 1.14 |
Doctor or health care provider | 1.89 | 1.22 | 2.04 | 1.21 | 1.92 | 1.28 | 1.89 | 1.21 |
News on the radio, TV, online, or in newspapers | 1.17 | 1.05 | 1.28 | 1.05 | 1.14 | 1.09 | 0.99 | 1.03 |
Average overall | 1.36 | 0.98 | 1.55 | 1.04 | 1.46 | 1.09 | 1.25 | 0.94 |
Trust—Unofficial Source of COVID-19 Information 1 | Mean | SD | Mean | SD | Mean | SD | Mean | SD |
Faith leaders | 1.18 | 1.28 | 0.98 | 1.17 | 0.65 | 1.04 | 1.36 | 1.24 |
Close friends and family members | 1.58 | 1.17 | 1.59 | 1.12 | 1.37 | 1.10 | 1.63 | 1.17 |
Classmates, colleagues or other people you know | 1.27 | 1.08 | 1.34 | 1.06 | 1.20 | 1.01 | 1.26 | 1.03 |
Contacts on social media | 0.81 | 0.94 | 0.77 | 0.94 | 0.77 | 0.94 | 0.75 | 0.93 |
Average overall | 1.21 ttt | 0.90 | 1.17 t | 0.85 | 1.00 | 0.84 | 1.25 tt | 0.87 |
Consumption—Official Source of COVID-19 Information 2 | ||||||||
Local government officials (e.g., Governor, Mayor) | 1.44 | 1.17 | 1.63 | 1.19 | 1.52 | 1.21 | 1.36 | 1.08 |
Federal government (e.g., President, White House Coronavirus Task Force) | 1.42 | 1.15 | 1.55 | 1.21 | 1.51 | 1.27 | 1.31 | 1.09 |
Print or online news | 1.40 | 1.13 | 1.42 | 1.10 | 1.38 | 1.2 | 1.41 | 1.08 |
TV or radio | 1.38 | 1.15 | 1.39 | 1.07 | 1.24 | 1.11 | 1.26 | 1.04 |
Healthcare providers (e.g., Personal Physician/Doctor, Pharmacist, etc.) | 1.84 | 1.26 | 1.74 | 1.28 | 1.66 | 1.29 | 1.71 | 1.28 |
Medical/Health websites (e.g., CDC, WebMD, etc.) | 1.64 | 1.20 | 1.69 | 1.20 | 1.65 | 1.31 | 1.60 | 1.18 |
Average overall | 1.52 | 1.02 | 1.57 | 1.01 | 1.49 | 1.06 | 1.44 | 0.92 |
Consumption—Unofficial Source of COVID-19 Information 2 | ||||||||
Friends, family or neighbors (not including social media) | 1.47 | 1.14 | 1.35 | 1.08 | 1.24 | 1.11 | 1.64 | 1.28 |
Social media (e.g., Instagram, Facebook, YouTube, TikTok, etc.) | 1.08 | 1.07 | 0.97 | 1.03 | 0.86 | 1.09 | 1.29 | 1.16 |
Average overall | 1.28 ttt | 0.98 | 1.16 | 0.94 | 1.05 | 0.98 | 1.47 ttt | 1.09 |
(a) | (b) | (c) | |||
Trust—Official Source of COVID-19 Information † | Received COVID-19 Vaccine ^ | Trust—Unofficial Source of COVID-19 Information ‡ | |||
Consumption—Official Source | 0.671*** (0.030) | Trust—Official Source 1 | 0.532 *** (0.060) | Consumption—Unofficial Source | 0.375 *** (0.029) |
Trust—Unofficial Source 1 | −0.321 *** (0.065) | ||||
Age | 0.003 (0.002) | Age | 0.023 *** (0.003) | Age | 0.004 ** (0.002) |
Race/Ethnicity—NHPI | −0.127 (0.079) | Race/Ethnicity—NHPI | −0.013 (0.138) | Race/Ethnicity—NHPI | 0.177 ** (0.085) |
Race/Ethnicity—Asian | 0.052 (0.090) | Race/Ethnicity—Asian | 0.223 (0.160) | Race/Ethnicity—Asian | 0.170 * (0.097) |
Race/Ethnicity—Other | −0.279 ** (0.118) | Race/Ethnicity—Other | −0.381 ** (0.192) | Race/Ethnicity—Other | 0.068 (0.128) |
Gender—Male | 0.114 ** (0.052) | Gender—Male | 0.030 (0.087) | Gender—Male | −0.028 (0.057) |
Education—High school graduate or GED completed | −0.043 (0.127) | Education—High school graduate or GED completed | 0.206 (0.202) | Education—High school graduate or GED completed | −0.033 (0.138) |
Education—Some college level/Technical/Vocational degree | −0.010 (0.131) | Education—Some college level/Technical/Vocational degree | 0.571 *** (0.209) | Education—Some college level/Technical/Vocational degree | 0.076 (0.142) |
Education—Bachelor’s degree | 0.055 (0.138) | Education—Bachelor’s degree | 0.962 *** (0.222) | Education—Bachelor’s degree | 0.081 (0.150) |
Education—Other advanced degree (Master’s, Doctoral degree) | 0.115 (0.136) | Education—Other advanced degree (Master’s, Doctoral degree) | 1.132 *** (0.222) | Education—Other advanced degree (Master’s, Doctoral degree) | 0.044 (0.148) |
Constant | 0.417 ** (0.164) | Constant | −1.430 *** (0.272) | Constant | 0.674 *** (0.178) |
Observations | 752 | Observations | 1.124 | Observations | 752 |
R2 | 0.444 | Log Likelihood | −622.168 | R2 | 0.193 |
Adjusted R2 | 0.437 | Akaike Inf. Crit. | 1.268.337 | Adjusted R2 | 0.182 |
Residual Std. Error | 0.668 (df = 741) | Residual Std. Error | 0.724 (df = 730) | ||
F Statistic | 59.207 *** (df = 10; 741) | F Statistic | 17.694 *** (df = 10; 741) |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Juarez, R.; Phankitnirundorn, K.; Okihiro, M.; Maunakea, A.K. Opposing Role of Trust as a Modifier of COVID-19 Vaccine Uptake in an Indigenous Population. Vaccines 2022, 10, 968. https://doi.org/10.3390/vaccines10060968
Juarez R, Phankitnirundorn K, Okihiro M, Maunakea AK. Opposing Role of Trust as a Modifier of COVID-19 Vaccine Uptake in an Indigenous Population. Vaccines. 2022; 10(6):968. https://doi.org/10.3390/vaccines10060968
Chicago/Turabian StyleJuarez, Ruben, Krit Phankitnirundorn, May Okihiro, and Alika K. Maunakea. 2022. "Opposing Role of Trust as a Modifier of COVID-19 Vaccine Uptake in an Indigenous Population" Vaccines 10, no. 6: 968. https://doi.org/10.3390/vaccines10060968
APA StyleJuarez, R., Phankitnirundorn, K., Okihiro, M., & Maunakea, A. K. (2022). Opposing Role of Trust as a Modifier of COVID-19 Vaccine Uptake in an Indigenous Population. Vaccines, 10(6), 968. https://doi.org/10.3390/vaccines10060968